Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Milger, K; Kneidinger, N; Neurohr, C; Reichenberger, F; Behr, J.
Switching to nintedanib after discontinuation of pirfenidone due to adverse events in IPF.
Eur Respir J. 2015; 46(4):1217-21
Doi: 10.1183/13993003.00584-2015
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Milger-Kneidinger Katrin
- Co-Autor*innen der Med Uni Graz
- Kneidinger Nikolaus
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Find related publications in this database (using NLM MeSH Indexing)
- Adult - administration & dosage
- Aged - administration & dosage
- Aged, 80 and over - administration & dosage
- Anti-Inflammatory Agents - therapeutic use
- Body Mass Index - administration & dosage
- Compassionate Use Trials - administration & dosage
- Enzyme Inhibitors - adverse effects, therapeutic use
- Female - administration & dosage
- Humans - administration & dosage
- Idiopathic Pulmonary Fibrosis - drug therapy
- Indoles - therapeutic use
- Male - administration & dosage
- Middle Aged - administration & dosage
- Pyridones - adverse effects, therapeutic use
- Respiratory Function Tests - administration & dosage
- Retrospective Studies - administration & dosage
- Vital Capacity - administration & dosage